2000
DOI: 10.1002/(sici)1098-1136(20000201)29:3<222::aid-glia4>3.0.co;2-0
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of striatal lesions produced by glutamate uptake alteration: Cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
54
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 72 publications
(56 citation statements)
references
References 57 publications
(77 reference statements)
2
54
0
Order By: Relevance
“…GLAST and GLT-1 are expressed primarily in glial cells, whereas EAAC1 is the predominant neuronal GT (Robinson and Dowd, 1997;Danbolt, 2001). Both neuronal and glial GTs actively participate in a number of fundamental physiological functions, including synaptic plasticity, by regulating extracellular glutamate concentration (Mennerick et al, 1999;Lievens et al, 2000;Vorwerk et al, 2000;Trotti et al, 2001). Importantly, GTs regulate the duration and intensity of glutamate receptor activation during signal transduction.…”
Section: Introductionmentioning
confidence: 75%
See 3 more Smart Citations
“…GLAST and GLT-1 are expressed primarily in glial cells, whereas EAAC1 is the predominant neuronal GT (Robinson and Dowd, 1997;Danbolt, 2001). Both neuronal and glial GTs actively participate in a number of fundamental physiological functions, including synaptic plasticity, by regulating extracellular glutamate concentration (Mennerick et al, 1999;Lievens et al, 2000;Vorwerk et al, 2000;Trotti et al, 2001). Importantly, GTs regulate the duration and intensity of glutamate receptor activation during signal transduction.…”
Section: Introductionmentioning
confidence: 75%
“…Regulation of regional glutamate uptake has been linked critically to the prevention of glutamate neurotoxicity as well as the pathogenesis of neurological disorders, including brain ischemia, epilepsy, amyotrophic lateral sclerosis, spinal cord injury, and Alzheimer's disease (Mennerick et al, 1999;Lievens et al, 2000;Vorwerk et al, 2000;Bigini et al, 2001;Trotti et al, 2001;VeraPortocarrero et al, 2002). The present findings suggest a new strategy for treating neuropathic pain by reducing regional glutamate availability and preventing glutamate overexcitation via an enhanced GT system.…”
Section: Contributions To the Central Mechanisms Of Neuropathic Painmentioning
confidence: 98%
See 2 more Smart Citations
“…The complexity of the mechanisms involved in glutamatergic neurotransmission makes it already apparent that a number of 10/48 abnormalities, pre-synaptic, post-synaptic or glial, alone or in combination can be excitotoxic. For example, a loss of selectivity of ionotropic receptors [49], or deficiencies in glial re-uptake of glutamate [55] are observed in lateral amyotrophic sclerosis. In drug abuse, synaptic glutamate dysfunctions contribute to explain phenomena such as the effectiveness of either a mGluR1, mGluR5 or NMDA antagonist to inhibit the up regulation of endoplasmic reticulum stress protein due to acute and chronic cocaine administration [3].…”
Section: Excitotoxicity and Neurodegenerationmentioning
confidence: 99%